Skip to main content

Advertisement

Log in

Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

The rapid increase in fentanyl overdose deaths, particularly those also attributed to stimulants, has led to concerns about unintentional fentanyl exposure. Utilizing vital and medical record data, we identified overdose decedents from 2018 to 2021 in San Francisco who received care in the safety net system in the 3 years preceding death. Among 506 decedents, medical record evidence of pre-mortem opioid use was present for 48% of stimulant-only, 56% of stimulant-fentanyl, 65% of fentanyl-only, and 82% of non-fentanyl opioid decedents (p<0.001). Among stimulant-fentanyl decedents, an increase in 10 years of age (adjusted odds ratio (aOR) 0.74 [95% CI:0.59–0.94]) and race other than White or Black (aOR 0.36 [95% CI:0.15–0.87]) had lower odds of evidence of pre-mortem opioid use. While not conclusive, these findings raise the possibility that a significant proportion of fentanyl overdose decedents in San Francisco may have not intended to consume an opioid on the occasion of their death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep 2021;70(6):202–7.

    Article  Google Scholar 

  2. Centers for Disease Control and Prevention. National Center for Health Statistics Mortality Data on CDC Wonder. Available at: https://wonder.cdc.gov/mcd.html. Published 2021. Accessed 2 Oct 2021.

  3. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction 2003;98(6):739–47.

    Article  Google Scholar 

  4. Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344–50.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention. Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids. Available at: https://emergency.cdc.gov/han/HAN00413.asp. Published 2018. Accessed 4 Dec 2021.

  6. Nolan ML, Shamasunder S, Colon-Berezin C, Kunins HV, Paone D. Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention. J Urban Health 2019;96(1):49–54.

    Article  Google Scholar 

  7. Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend 2018;190:242–5.

    Article  Google Scholar 

  8. Bauer LK, Brody JK, Leon C, Baggett TP. Characteristics of homeless adults who died of drug overdose: a retrospective record review. J Health Care Poor Underserved 2016;27(2):846–59.

    Article  Google Scholar 

  9. Kral AH, Lambdin BH, Browne EN, et al. Transition from injecting opioids to smoking fentanyl in San Francisco, California. Drug Alcohol Depend 2021;227:109003.

    Article  Google Scholar 

Download references

Acknowledgements

This project was supported by NIDA grant K24DA042720 and CDC grant R01CE003364.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phillip O. Coffin.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Table 2 Characteristics of stimulant and opioid decedents in and out of safety net care
Table 3 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved a stimulant (n=140)
Table 4 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved a stimulant and fentanyl (n=220)
Table 5 Demographic characteristics, evidence of pre-mortem opioid use, and involvement of a benzodiazepine in death among deaths that only involved another opioid (not fentanyl) (n=112)
Table 6 Proportion of decedents with evidence of pre-mortem opioid use by substances involved in death and demographics (n=506)
Table 7 Results of multivariable logistic regression analysis of demographic characteristics associated with evidence of opioid use in 3 years preceding death among stimulant-fentanyl decedents (n=220)
Table 8 Results of multivariable logistic regression analysis of demographic characteristics associated with evidence of clinical history of opioid use in 3 years preceding death among fentanyl deaths (n=254)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coffin, P.O., McMahan, V.M. & Murphy, C. Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System. J Urban Health 99, 865–872 (2022). https://doi.org/10.1007/s11524-022-00663-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11524-022-00663-1

Keywords

Navigation